Director/PDMR Shareholding Replacement

RNS Number : 7718K
GlaxoSmithKline PLC
20 July 2011
 



This announcement replaces the original announcement released on 11 July 2011 at 15.19 (RNS No: 1709K).

 

The Company was notified on the 20 July 2011 of a correction to the date at which the interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons changed, arising through the purchase of Ordinary shares through the Share Reward Plan.

 

Save as disclosed above and the revised date shown below, all other details remain unchanged.

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of 1369.704 pence per Ordinary share on 8 July 2011 through the Company's Share Reward Plan ("the Plan").

 

Mr A P Witty

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S M Bicknell

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr E J Gray

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S A Hussain

Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Dr D Pulman

Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D S Redfern

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Ms C Thomas

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr P C Thomson

Acquisition of 12 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Dr P J T Vallance

Acquisition of 14 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mrs V A Whyte

Acquisition of 25 Ordinary shares under the Dividend Reinvestment element of the Plan

 

 

The Company and the above-mentioned persons were advised of this information on 11 July 2011.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

11 July 2011


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMGZNVGDGMZM

Companies

GSK (GSK)
UK 100

Latest directors dealings